Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Total non-GAAP adjustments before income taxes by Quarter
Total non-GAAP adjustments before income taxes ($M) ($M)
Gilead Sciences Total non-GAAP adjustments before income taxes: $2,722M in Q2 2026, up 303.3% from a year earlier.
Where the Q2 2026 figure comes from
“|| Total non-GAAP adjustments before income taxes | 2,722 | 675 | 3,262 | 1,757”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-08-04) ↗
Reported in Form 8-K Non-GAAP Adjustment Summary.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up total non-GAAP adjustments before income taxes
- Total non-GAAP adjustments to costs and expenses ($M)3,065 · Q2 2026
- Non-GAAP R&D adjustments ($M)335 · Q2 2026
- Non-GAAP other income (expense) adjustments (equity securities fair value, $M)-343 · Q2 2026
- Income tax effect of non-GAAP adjustments ($M)-574 · Q2 2026
- Discrete and related tax charges (benefits) ($M)44 · Q2 2026
- Total non-GAAP adjustments after tax ($M)2,105 · Q2 2026
Cite this data
StockData. (2026). Gilead Sciences Total non-GAAP adjustments before income taxes ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-adj-pretax
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.